Prostate Cancer

Dr. Christopher Barbieri completed both his Urology Residency and Urologic Oncology Fellowship at Weill Cornell Medical College. He received his undergraduate degree from Dartmouth College and then attended Vanderbilt University School of Medicine, where he obtained both his MD and PhD degrees. Dr. Barbieri's research interests include using genomic data to define distinct molecular subclasses of urologic malignancy, with a particular focus on prostate cancer.

Urologic oncology is a multidisciplinary field that incorporates innovative surgical technology, systemic treatments such as chemotherapy, as well as a focused research effort.  As a Professor of Urology and the Clinical Director of Urologic Oncology, I continually interact with colleagues in the areas of medical oncology, radiation oncology, and pathology, among others, in order to provide the most comprehensive and innovative care for our patients with prostate, bladder, kidney and testicular cancer.

Dr. Jim Hu is a urologic oncologist with his undergraduate degree in Economics, his Master’s in Public Health in HealtPolicy and Management from Johns Hopkins University, and his Medical Degree from Baylor College of Medicine. He completed his Urology Residency at the David Geffen School of Medicine at UCLA and his Robotic Surgery/Urologic Oncology Fellowship in 2004 at City of Hope National Medical Center.

Dr. Schlegel is an internationally acclaimed expert in the treatment of male infertility, especially the interface of male factor treatment with assisted reproductive techniques. His work has also clarified the importance of hormonal therapy, sperm analysis and genetic studies in the evaluation of men with infertility. He was awarded the 1996 Established Clinician Award by The European Society for Human Reproduction and Embryology.